Blend Labs Q2 Adj EPS $(0.09) Beats $(0.13) Estimate, Sales $42.81M Beat $40.11M Estimate
Portfolio Pulse from vinayak@benzinga.com
Blend Labs (NYSE:BLND) reported Q2 adjusted EPS of $(0.09), beating the estimate of $(0.13) by 30.77%. This is a 52.63% increase over losses from the same period last year. Quarterly sales were $42.81M, beating the estimate of $40.11M by 6.74%, but this is a 34.67% decrease over sales from the same period last year.
August 09, 2023 | 8:31 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Blend Labs reported better than expected Q2 results but showed a significant decrease in sales compared to the same period last year.
Blend Labs reported better than expected earnings for Q2, which is positive for the stock. However, the significant decrease in sales compared to the same period last year could be a concern for investors, potentially offsetting the positive earnings news.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100